Calls for Expression of Interest for SGA2

 
 

Apply to be a Scientific Chair for the HBP 2019 Education Workshop series

Through this Call for Expressions of Interest (CEoI), the HBP Education Programme will identify Scientific Chairs (from within and outside the HBP) who are taking over the scientific lead of HBP Education Workshops. In total, five proposals will be selected for May/June/July 2019.

HBP Education Workshops are short teaching formats of two to three days of length. The workshop themes are related to a specific online course on an advanced basic level considering the audience comes from different scientific backgrounds and different levels of education (Master, PhD, early post-docs). Proposals can be submitted for the following themes:
•    ICT/Computing for non-specialists
•    Neuroscience/Neurobiology for non-specialists
•    Brain medicine for non-specialists
•    Research, Ethics and Societal Impact
•    Intellectual Property Rights, Translation and Exploitation of Research

A workshop covering each theme will be held once a year, for a total of five workshops in 2019. For 2019, any date in May, June and July can be claimed for a workshop.

Application details are here: https://opencalls.humanbrainproject.eu/forms/overview/hbp-workshop19

 

UPCOMING CALLS

Call for the HBP Infrastructure Voucher Programme

 

As part of its SGA2 activities (2018-2020) the Human Brain Project has developed an Infrastructure Voucher Programme that will enable non-HBP researchers to secure HBP engineering solutions for their challenging scientific problems.

The programme call, which will get underway in August 2018, has been developed to open the HBP's platform infrastructure to meet the needs of the user community in a new dynamic way.

It is open to all non-HBP researchers worldwide, with target groups from academic and medical research (including hospitals), and industry and pharma (SMEs and companies).

The voucher programme aims to establish successful win-win collaborations and pursue technology innovation and engineering solutions of mutual interest. The idea is that interested applicants get in contact with the HBP during the application process to work together on the proposals.

Important note: While benefiting from tailor made developments and solutions for their projects, voucher winners will not receive any direct funding for their work from the HBP. The vouchers fund the work of the HBP platform engineering teams to implement the feature requests of the external projects.

The total budget is Euro 1.23 million and the size of each voucher will depend on the personnel and travel costs required to put the selected projects into practice and to guarantee intensive exchange between the participants. The vouchers are worth between 6 to 12 months of engineering/development time.

Application process & planned timeline

Call opens in August 2018 and will close in October 2018. The announcement of the winners is expected for the end of November 2018. The practical work of the platform developers will start afterwards. The voucher projects end on 31 March 2020.
For more information, please contact

info@opencalls.humanbrainproject.eu

____________________________

 

Results of the first round (closed September 2017) of Calls for Expression of Interest for the second Specific Grant Agreement (SGA2)

5 projects were selected for EC funding from April 2018 to March 2020 (SGA2 phase) and the new partners will be integrated to the HBP Consortium.

The HBP launched 5 CEoIs from July 2017 to September 2017 with the objective to adding new partners to the HBP Consortium which will contribute to the development of the HBP Platform and increase the scope of their application, in terms of neuroscience and clinical research.

Over a total of 18 admissible and eligible proposals submitted within the calls deadline, 5 successful projects were selected for EC funding.

  • SINGLE will work on Comparative single cell analyses of principal neurons and Interneurons in mice and humans. Coordinator: German Centre for Neurodegenerative diseases (DZNE), Germany
  • HiPlan and TVB will contribute to Co-designing the HBP digital infrastructure for advancing the understanding of multilevel brain organization. Coordinators: National Research Council of Italy (CNR), Italy; Charité Universitätsmedizin Berlin (CHARITE), Germany
  • MAP-DRUG will assess Modelling allosteric drugs. Coordinator: Biomedical Research Foundation Academy of Athens (BRFAA), Greece
  • WE ARE HBP will further promote the Coordination of Gender Equality Activities. Coordinator: convelop cooperative knowledge design GmbH (convelop), Austria

 

-------------------------------------------------------------------

Recently closed calls (closed 15 March 2018)

Testing pathophysiological models of brain diseases - Medical Informatics Platform

This Call for Expression of Interest (CEoI) is addressed to organisations interested in pathophysiological models of brain disease, in the field of Psychiatry or Neurology.

The objective of this CEoL is to develop a specific, hypothesis-driven use case, by testing the validity of one or more original, promising, elaborated pathophysiological models of brain disease(s) using MIP-driven analysis of large-scale clinical data. These models shall incorporate knowledge from one or more of the following fields: systems biology and systems neuroscience; neuroinformatics; computational neuroscience; and any other relevant contributing field. This knowledge might be provided by activities developed by other HBP Subprojects covering these various fields.

The model(s) might cover specific brain diseases or, alternatively, tackle mechanisms thought to operate across diseases, or challenge current classification of brain disorders. Applicants are encouraged to involve clinicians in the model validation, to strengthen its potential clinical impact.

The predictive models tested should prioritise the validation of potential clinically-relevant biomarkers, which could then be implemented in clinical practice.

This CEoI was open from 29 January 2018 and closed on 15 March 2018.

Testing pathophysiological models of brain diseases(EUR 850,000, including 25% of Indirect Costs)

Click the link above for further details on this Call and submission process.

For questions regarding this CEoI please email: model-testing@opencalls.humanbrainproject.eu

_______________________

Federated analysis of human intracerebral stimulation and recording data - Medical Informatics Platform

This Call for Expression of Interest (CEoL) is addressed to organisations specialised in the fields of human intracerebral stimulation and recording data obtained during procedures of deep brain stimulation (DBS) for psychiatric or neurological diseases requiring such treatment (e.g. movement disorders), as well as during stereoelectroencephalography (SEEG) investigations for epilepsy surgery.

The objective of this call is to recruit into the HBP a partner or group of partners which will develop and run an operational framework for federated analyses of human intracerebral stimulation and recording data, as well as integrating the results with computational modelling, neuroscience, brain atlasing, neuroinformatics, etc., in order to gain further insights into:

  • the relationship between the location of intracerebral electrodes and patients’ clinical outcomes
  • the pathophysiological mechanisms of the various conditions investigated or treated with intracerebral electrodes (e.g. epilepsy and movement disorders), as well as improved therapeutic perspectives
  • the physiology and functional role of the various brain structures investigated with intracerebral electrodes in human subjects
  • the relationship between electrophysiological measures, recommendations for surgery and patients’ post-surgery clinical outcomes.

The applicants should ensure that their study will not promote indications for DBS that raise ethical issues.

This CEoI was open from 29 January 2018 and closed on 15 March 2018.

Federated analysis of human intracerebral stimulation and recording data (EUR 850,000, including 25% of Indirect Costs)

Click the link above for further details on this Call and submission process.

For questions regarding this CEoI please email: intracerebral@opencalls.humanbrainproject.eu

_______________________

 

Comprehensive ontologies for brain diseases - Medical Informatics Platform

This Call for Expression of Interest (CEoL) is addressed to organisations interested in Ontologies, in particular in the field of brain diseases. Ontologies represent the foundation of any project based on the collection and analysis of medical data. This applies even more particularly to the objectives of the Medical Informatics Platform (MIP), according to the heterogeneity, diversity and complexity of the hospital data made available through the MIP network. In this context, it is essential to establish a comprehensive set of ontologies that will allow leveraging of the research potential of the MIP.

The objective of the call is to develop a broad set of ontologies, covering a wide range of brain diseases and types of data. The development of these ontologies should take into account or be consistent with:

  • the structure of available hospital data
  • the general architecture of the MIP
  • existing, well accepted or recommended ontologies and common data elements, in particular those approved by scientific societies.

In addition, they should promote a transdisciplinary approach across current diseases classifications.

This CEoI was open from 29 January 2018 and closed on 15 March 2018.

Comprehensive ontologies for brain diseases (EUR 314,000, including 25% of Indirect Costs)

Click the link above for further details on this Call and submission process.

For questions regarding this CEoI please email: ontologies@opencalls.humanbrainproject.eu

_______________________

 

Background on the Calls

The Human Brain Project (HBP) aims to bring a large number of users to the HBP-Joint Platform  to make it even more attractive for the external science community and to foster new collaborations across the full width of the HBP’s Subprojects. To achieve this, a substantial amount of funding has been made available in the next two-year funding period (the SGA2) for partner organisations to help contribute.

The HBP has asked potential new Partners to submit proposals (see recently closed calls below) that will directly contribute to the development of the HBP Platforms and increase the scope of their application, in terms of neuroscience and clinical research. The selected Partners will become full Partners in the HBP Consortium.  The projects will run from April 2018 to March 2020 (SGA2 phase).

Please note that for some of the CEoIs, current Partners of the HBP Consortium are explicitly invited to write a proposal with new Partners and apply together. Details will be explicitly laid out in the Guide for Applicants.

(Please note: Funding for the CEoIs for SGA2 are dependent on the successful application of the HBP to the European Commission (EC) for this next funding phase. SGA2 currently is in the Grant Preparation Phase.)

 

Frequently Asked Questions

Read our Frequently Asked Questions page.

 

SGA2 CEoI evaluation Process

 

Independent external evaluators will assess the submitted proposals. This remote evaluation process will be followed by a physical panel meeting, which will make the final selection.

The selected projects will be funded via the European Commission grant for SGA2.

The CEoI are managed by the Technische Universität München (TUM) together with the coordinator Swiss Federal Institute of Technology Lausanne (EPFL) on behalf of the HBP Consortium. Applications will be received through the ECHORD++ system, kindly provided by TUM.

 

Recently Closed Calls

  • HBP Schools for SGA2
  • HBP Workshops 2018
  • Co-designing the HBP digital infrastructure for advancing the understanding of multilevel brain organisation
  • Coordination of Data Protection in the HBP
  • Modelling allosteric drugs
  • Coordination of gender equality activities
  • Comparative single cell analyses of principal neurons and Interneurons in mice and humans